01
Apr
Funding available for the development and testing of therapeutics to treat COVID-19
Comments
Subject: Grants for companies: LifeArc COVID-19 therapeutics grant application deadline 6 April
LifeArc, a UK based medical research charity formerly known as MRC Technology, has opened a £10m grant funding opportunity for companies, NHS employees or academics from anywhere in the world working to develop therapeutics for COVID-19.
Detail and how to apply here: https://www.lifearc.org/funding/covid-19/covid-19-funding/
What: LifeArc has made available an initial £10M for the identification of therapeutics that can be rapidly deployed to treat COVID-19. The aim is to run trials in patients during the current epidemic. It is anticipated that applications will be for funding to repurpose one or more drugs that are generic, already licensed, or are in late stage development for another indication.
When: The funding call opened on Friday 20th March and the deadline for applications is 6th April. Funds could be released very rapidly following a funding decision.
